<?xml version="1.0" encoding="UTF-8"?>
<p>Drug repositioning can be done by a variety of approaches, such as different routes of administration, combining two different existing drugs for a new indication and enhancing or altering existing formulations [
 <xref rid="B11-viruses-12-01058" ref-type="bibr">11</xref>]. For instance, a study conducted on a modified drug, carbamazepine ER (extended-release), has shown a fruitful outcome where there were significantly less patients who suffered from the adverse effects upon administration of Carbamazepine ER as compared to the traditional IR (immediate-release) at 6 versus 36 in 48 patients [
 <xref rid="B6-viruses-12-01058" ref-type="bibr">6</xref>].
</p>
